“Each year we find ourselves in some new situation, facing new challenges. We add to the excitement by providing scientific assessments, participating in international projects and contributing to the development of our field. Only by challenging ourselves can we learn our true strengths and capabilities, and fully participate in life,“ said Katrin Kiisk, the Director General of the State Agency of Medicines.
While 2022 was largely a year of introspection for the Agency, focusing on internal and national contingency planning, 2023 will be remembered as the year of international cooperation
In addition to the usual summaries, the report also highlights the work and outcomes of the laboratory, clinical trials, IT developments, as well as cooperation on the national and international level.
Agency’s yearbook in English can be found HERE.